# Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia

> **NCT07007936** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Anemia
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee

## Interventions

- **DRUG:** SSS17 Capsule (6 Dose Levels)
- **DRUG:** Placebo Drug

## Key facts

- **NCT ID:** NCT07007936
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007936, "Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07007936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*